Obstructive sleep apnoea treatment and fasting lipids: A comparative effectiveness study

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 405-414

  Keenan, Brendan T ^a   Maislin, Greg ^a   Sunwoo, Bernie Y ^a   Arnardottir, Erna Sif ^b,c   Jackson, Nicholas ^a   Olafsson, Isleifur ^b   Juliusson, Sigurdur ^c   Schwab, Richard J ^a   Gislason, Thorarinn ^b,c   Benediktsdottir, Bryndis ^b,c   Pack, Allan I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOXIA; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROPENSITY SCORE; SLEEP DISORDERED BREATHING; WAIST HIP RATIO; AGED; ANOXIA; ANTHROPOMETRY; ATHEROSCLEROSIS; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CHEMISTRY; COHORT ANALYSIS; ICELAND; METABOLISM; MIDDLE AGED; OBSERVATIONAL STUDY; PRESSURE; QUESTIONNAIRE; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

AGED; ANOXIA; ANTHROPOMETRY; ATHEROSCLEROSIS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; CONTINUOUS POSITIVE AIRWAY PRESSURE; FASTING; FEMALE; HUMANS; ICELAND; LIPIDS; MALE; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY AS TOPIC; PRESSURE; QUESTIONNAIRES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84905654704     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00043614     Document Type: Article

References (41)

1. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009; 51: 434-451.
2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-325.
3. McArdle N, Hillman D, Beilin L, et al. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007; 175: 190-195. (Pubitemid 46115091)
4. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001; 154: 50-59. (Pubitemid 32565686)
5. Chou YT, Chuang LP, Li HY, et al. Hyperlipidaemia in patients with sleep-related breathing disorders: prevalence and risk factors. Indian J Med Res 2010; 131: 121-125.
6. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-741. (Pubitemid 38647933)
7. Roche F, Sforza E, Pichot V, et al. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 2009; 10: 882-886.
8. Robinson GV, Pepperell JC, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004; 59: 777-782. (Pubitemid 39215375)
9. Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2010; 17: 161-165.
10. Adedayo AM, Olafiranye O, Smith D, et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 2014; 18: 13-18.
11. Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011; 140: 534-542.
12. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29: 720-727. (Pubitemid 46554622)
13. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011; 184: 1192-1199.
14. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176: 706-712. (Pubitemid 47503079)
15. Phillips CL, Yee BJ, Marshall NS, et al. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med 2011; 184: 355-361.
16. Steiropoulos P, Tsara V, Nena E, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2007; 132: 843-851.
17. Savransky V, Nanayakkara A, Li J, et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007; 175: 1290-1297. (Pubitemid 46905755)
18. Jun J, Polotsky VY. Sleep disordered breathing and metabolic effects: evidence from animal models. Sleep Med Clin 2007; 2: 263-277.
19. Li J, Savransky V, Nanayakkara A, et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 2007; 102: 557-563. (Pubitemid 46220883)
20. Drager LF, Li J, Shin MK, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J 2012; 33: 783-790.
21. Drager LF, Yao Q, Hernandez KL, et al. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med 2013; 188: 240-248.
22. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation 2007; 115: 2340-2343.
23. Lieu TA, Au D, Krishnan JA, et al. Comparative effectiveness research in lung diseases and sleep disorders recommendations from the National Heart, Lung, and Blood Institute workshop. Am J Respir Crit Care Med 2011; 184: 848-856.
24. Maislin G, Rubin DB. Design of non-randomized medical device trials based on sub-classification using propensity score quintiles, topic contributed session on medical devices. Proc Joint Stat Meet 2010; 2186-2196.
25. Rubin DB. For objective causal inference, design trumps analysis. Ann Appl Stat 2008; 2: 808-840.
26. Arnardottir ES, Maislin G, Jackson N, et al. The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: the Icelandic Sleep Apnea Cohort study. Int J Obes (Lond) 2013; 37: 835-842.
27. Maislin G, Ahmed MM, Gooneratne N, et al. Single slice vs. volumetric MR assessment of visceral adipose tissue: reliability and validity among the overweight and obese. Obesity (Silver Spring) 2012; 20: 2124-2132.
28. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
29. Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006; 27: 1431-1439. (Pubitemid 43998077)
30. Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology 2007; 132: 2181-2190. (Pubitemid 46693753)
31. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707. (Pubitemid 26140808)
32. Sharma SK, Agrawal S, Damodaran D, et al. Retraction: CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011; 365: 2277-86.
33. N Engl J Med 2013; 369: 1770.
34. Quan SF, Budhiraja R, Clarke DP, et al. Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea. J Clin Sleep Med 2013; 9: 989-993.
35. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353: 2100-2105. (Pubitemid 29278478)
36. Kezirian EJ, Kirisoglu CE, Riley RW, et al. Resting energy expenditure in adults with sleep disordered breathing. Arch Otolaryngol Head Neck Surg 2008; 134: 1270-1275.
37. Stenlof K, Grunstein R, Hedner J, et al. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 1996; 271: E1036-E1043.
38. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5: 173-178. (Pubitemid 351237875)
39. Weaver TE, Kribbs NB, Pack AI, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997; 20: 278-283. (Pubitemid 27276642)
40. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-1114. (Pubitemid 29202543)
41. Budhiraja R, Parthasarathy S, Drake CL, et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep 2007; 30: 320-324. (Pubitemid 46494407)